BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical hol

BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“A

Oppenheimer analyst Les Sulewski initiates coverage on Amneal Pharmaceuticals (NASDAQ:AMRX) with

Wall Street analysts made mixed price-target changes for LYFT, AMRX, JBHT, CRM, APPF, FLNC and CRWD.

Barclays analyst Glen Santangelo maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight

Leerink Partners analyst Daniel Clark initiates coverage on Amneal Pharmaceuticals (NASDAQ:AMRX)

https://www.sec.gov/Archives/edgar/data/1723128/000114036126035617/ny20081412x1_s3asr.htm

JP Morgan analyst Chris Schott reinstates Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight

UBS analyst Ashwani Verma maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Buy and raises th

Amneal Pharmaceuticals (NASDAQ:AMRX) raises FY2026 Adj EPS guidance from $0.95-$1.05 to $0.96-$1.06

Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.30 per share which beat the a

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up t

Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/m

UBS analyst Ashwani Verma maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Buy and raises th

On July 6, 2026, Alkermes plc (the "Company") and Amneal Pharmaceuticals LLC ("Amneal&#3

FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after recei

Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significan

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

3 health care stocks flashing warning: CAH RSI 77.7, TGTX RSI 79.8, AMRX RSI 76.9; all overbought, b

Overall Interim Findings (Entire Study Population, 214Patients; Six-Week Analysis)All 214 patients w

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ:AMRX) today announc

Barclays analyst Glen Santangelo maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight

Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars pla

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

The Trump administration backs off plans to impose tariffs on generic drugs after internal debate ov

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company a

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big

Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first

Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly e

  On Friday, 469 companies hit new 52-week lows.

  Thursday's session saw 337 companies set new 52-week lows.

  Tuesday's morning session saw 84 companies set new 52-week lows.

  On Friday, 497 companies set new 52-week lows.

  On Wednesday, 116 companies set new 52-week lows.

  On Tuesday, 93 companies set new 52-week lows.

  On Monday, 36 companies set new 52-week lows.

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

Companies Reporting Before The Bell • Sprott (NYSE:SII) is likely to report quarterly earnings at $

  On Tuesday, 838 companies hit new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Tuesday, 126 companies set new 52-week lows.

  On Thursday, 529 companies set new 52-week lows.

  On Wednesday, 238 companies achieved new lows for the year.